Pediatrics Vaccines Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
The Global Pediatrics Vaccines Market Size accounted for USD 51.0 Billion in 2022 and is projected to achieve a market size of USD 160.6 Billion by 2032 growing at a CAGR of 11.1% from 2023 to 2032.
Pediatrics Vaccines Market Key Highlights
- Global pediatrics vaccines market revenue is expected to increase by USD 160.6 Billion by 2032, with a 11.1% CAGR from 2023 to 2032
- North America region led with more than 38% of pediatrics vaccines market share in 2022
- The World Health Organization (WHO) estimates that vaccines prevent 2-3 million deaths per year worldwide
- According to the CDC, vaccination rates for children in the United States are generally high, with over 90% of children receiving most recommended vaccines
- By vaccine type, monovalent vaccines segment held a significant revenue share in the market in 2022
- Increasing use of alternative therapies, such as acupuncture and yoga, drives the pediatric vaccines market size
Pediatric vaccines are vaccines that are administered to children from birth to adolescence to protect them from various infectious diseases. These vaccines help to build immunity in children, making them less susceptible to diseases and reducing the spread of infectious diseases in the community. Pediatric vaccines are crucial to the health and well-being of children, as they can prevent serious illnesses, hospitalizations, and even death.
The market for pediatric vaccines has been growing steadily over the past few years. This growth is due to a number of factors, including increasing awareness about the importance of vaccines, the introduction of new vaccines, and rising government support for vaccination programs. In addition, the COVID-19 pandemic has increased the demand for vaccines, including pediatric vaccines, as people seek to protect themselves and their families from infectious diseases. In addition, the report highlights that the introduction of new vaccines, such as the HPV vaccine and the meningococcal vaccine, is also expected to drives the pediatrics vaccines market growth.
Global Pediatrics Vaccines Market Trends
Market Drivers
- Increasing prevalence of infectious diseases
- Growing awareness about the importance of vaccination
- Rising government support for vaccination programs
- Introduction of new vaccines
- Increasing demand for combination vaccines
Market Restraints
- High cost of vaccine development and production
- Stringent regulations and approval processes
Market Opportunities
- Growing demand for personalized vaccines
- Increasing focus on research and development for vaccine development
Pediatrics Vaccines Market Report Coverage
| Market | Pediatrics Vaccines Market |
| Pediatrics Vaccines Market Size 2022 | USD 51.0 Billion |
| Pediatrics Vaccines Market Forecast 2032 | USD 160.6 Billion |
| Pediatrics Vaccines Market CAGR During 2023 - 2032 | 11.1% |
| Pediatrics Vaccines Market Analysis Period | 2020 - 2032 |
| Pediatrics Vaccines Market Base Year | 2022 |
| Pediatrics Vaccines Market Forecast Data | 2023 - 2032 |
| Segments Covered | By Vaccine Type, By Technology, By Indication, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | GlaxoSmithKline (GSK), Merck & Co., Inc., Sanofi Pasteur, Pfizer Inc., Novartis International AG, CSL Limited, Johnson & Johnson, Bavarian Nordic, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Vaccination is a process or technique of improving the immunity of an individual against any specific infectious or chronic disease. So far, vaccination has saved a large number of lives including children, adults, and animals, thus furnishing them with a relatively better and healthier quality of life-saving and immunizing them against various infectious microorganisms such as bacteria and viruses. This is considered to be one of the most crucial reasons behind the rapid growth of the global pediatrics vaccines market value over the forecast period. In addition, vaccines are able to stimulate the immune systems of the human body in order to protect the concerned individual from subsequent diseases or infections. Vaccines are usually categorized into two main target markets such as pediatric and adult. Pediatric vaccines thus are most commonly employed for proper and efficient immunization of toddlers and children as well as adolescents against several infections such as diphtheria, diseases, hepatitis, influenza, meningococcal diseases, and pneumococcal diseases among others.
Rising non-government and government funding associated with the development of vaccines is one of the key factors driving the overall pediatric vaccine market over the forecast period. In addition, advancements in technology such as therapeutic and adjuvant vaccines are further anticipated to fuel the growth of the global pediatric vaccines market value over the forecast period. Additionally, increasing investments by various players in the market as well as key manufacturers of pediatric vaccines is further increasing the growth of the global market. Moreover, the increasing inclination of organizations as well as government bodies on immunization schedules prescribed by doctors for adolescents as well as raising awareness programs led by healthcare organizations such as WHO, UNICEF, and others are further projected to bolster the global pediatric vaccines market growth.
Pediatrics Vaccines Market Segmentation
The global pediatrics vaccines market segmentation is based on vaccine type, technology, indication, and geography.
Pediatrics Vaccines Market By Vaccine Type
- Monovalent
- Multivalent
According to the pediatrics vaccines industry analysis, the monovalent segment accounted for the largest market share in 2022. Monovalent vaccines are those that protect against a single disease, unlike combination vaccines that protect against multiple diseases. One of the primary drivers of the growth in the monovalent vaccine segment is the increasing demand for personalized healthcare. Monovalent vaccines provide healthcare professionals with the flexibility to customize vaccination schedules based on individual patient needs, and they may also reduce the risk of adverse reactions associated with combination vaccines. In addition, the increasing focus on preventive healthcare and the rising prevalence of infectious diseases have also contributed to the growth of the monovalent vaccine segment.
Pediatrics Vaccines Market By Technology
- Live Attenuated
- Conjugate
- Toxoid
- Inactivated
- Others
In terms of technology, the conjugate segment is expected to witness significant growth in the coming years. Conjugate vaccines are a type of vaccine that contains a bacterial polysaccharide linked to a protein, which enhances the immune response and provides longer-lasting immunity. One of the primary drivers of the growth in the conjugate vaccine segment is the increasing incidence of bacterial infections, particularly pneumococcal disease and meningococcal disease, which can cause serious illness and death. The introduction of conjugate vaccines for these diseases has significantly reduced the incidence of infections and has contributed to the growth of the conjugate vaccine segment. In addition, the increasing government support for vaccination programs and the rising demand for combination vaccines have also contributed to the growth of the conjugate vaccine segment.
Pediatrics Vaccines Market By Indication
- Influenza
- Varicella
- Pneumococcal Disease
- Measles, Mumps and Rubella
- Rotavirus
- Meningococcal Disease
- Human Papilloma Virus
- Polio
- Diphtheria, Pertussis and Tetanus
- Others
According to the pediatrics vaccines market forecast, the influenza segment is expected to witness significant growth in the coming years. Influenza, also known as the flu, is a highly contagious respiratory illness that can cause severe illness and even death, particularly in young children and the elderly. One of the primary drivers of the growth in the influenza vaccine segment is the increasing awareness about the importance of flu vaccination, particularly in children. The introduction of new influenza vaccines, such as quadrivalent vaccines that protect against four strains of the flu virus, has also contributed to the growth of the influenza vaccine segment. In addition, the increasing government support for flu vaccination programs and the rising demand for combination vaccines that protect against multiple diseases, including influenza, have also contributed to the growth of the influenza vaccine segment. Healthcare professionals are increasingly recommending flu vaccination for children, as it can reduce the risk of serious illness and hospitalization.
Pediatrics Vaccines Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Pediatrics Vaccines Market Regional Analysis
North America is dominating the pediatric vaccine market due to several factors. One of the primary factors is the well-established healthcare infrastructure in the region, which enables the easy availability and accessibility of pediatric vaccines. Additionally, the region has a high level of awareness about the importance of vaccination, and there are robust vaccination programs in place to ensure that children receive the recommended vaccines. Furthermore, North America has a large population of children who are eligible for vaccination, which has contributed to the growth of the pediatric vaccine market in the region. In addition, the increasing prevalence of infectious diseases, such as flu and meningococcal disease, has led to a higher demand for pediatric vaccines, further driving the growth of the market.
Pediatrics Vaccines Market Player
Some of the top pediatric vaccines market companies offered in the professional report include GlaxoSmithKline (GSK), Merck & Co., Inc., Sanofi Pasteur, Pfizer Inc., Novartis International AG, CSL Limited, Johnson & Johnson, Bavarian Nordic, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited.
Frequently Asked Questions
What was the market size of the global pediatric vaccines in 2022?
The market size of pediatric vaccines was USD 51.0 Billion in 2022.
What is the CAGR of the global pediatric vaccines market from 2023 to 2032?
The CAGR of pediatric vaccines is 11.1% during the analysis period of 2023 to 2032.
Which are the key players in the pediatric vaccines market?
The key players operating in the global market are including GlaxoSmithKline (GSK), Merck & Co., Inc., Sanofi Pasteur, Pfizer Inc., Novartis International AG, CSL Limited, Johnson & Johnson, Bavarian Nordic, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited.
Which region dominated the global pediatric vaccines market share?
North America held the dominating position in pediatric vaccines industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of pediatric vaccines during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global pediatrics vaccines industry?
The current trends and dynamics in the pediatric vaccines industry include increasing prevalence of infectious diseases, and growing awareness about the importance of vaccination.
Which vaccine type held the maximum share in 2022?
The monovalent vaccine type held the maximum share of the pediatric vaccines industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
